Atypical Lesions of the Breast and Lobular Carcinoma in Situ in Pregnancy – Surgeons’ Practice

Amant, Frédéric; Alipour, Sadaf; omranipour, ramesh; Eslami, Bita

doi:10.5152/ejbh.2019.5158

Atypical Lesions of the Breast and Lobular Carcinoma in Situ in Pregnancy – Surgeons’ Practice

Sadaf ALIPOUR, (Tehran University of Medical Sciences, Arash Women’s Hospital, Department of Surgery, Tehran, Iran)

Ramesh OMRANIPOUR, (Tehran University of Medical Sciences, Department of Surgical Oncology, Tehran, Iran)

Frederic AMANT, (Netherlands Cancer Institute and Amsterdam University Medical Centers, Center for Gynecologic Oncology Amsterdam, Amsterdam, Netherlands)

Bita ESLAMI (Tehran University of Medical Sciences, Breast Disease Research Center (BDRC), Tehran, Iran)

European Journal of Breast Health

2 1

Yıl: 2020 Cilt: 16 Sayı: 1 Sayfa Aralığı: 16 - 21 Metin Dili: İngilizce DOI: 10.5152/ejbh.2019.5158 İndeks Tarihi: 20-10-2020

Atypical Lesions of the Breast and Lobular Carcinoma in Situ in Pregnancy – Surgeons’ Practice

Öz:

Objective: Approach to precancerous and high-risk breast lesions occurring in pregnancy has received little attention in the literature. We carried out astudy to investigate the practice of surgeons in the management of these cases.Materials and Methods: A short survey was sent to surgeons, including a multiple-choice questionnaire about their practice for atypical hyperplasiaor lobular carcinoma in situ presenting in each trimester of pregnancy or at time of breastfeeding. Answer options included observation, immediate vacuumbiopsy, immediate surgery, surgery in next trimester, surgery after delivery, and surgery after end of breastfeeding; based on the time of presentation.Results: Out of the 671 practitioners invited, 97(14.5 %) responded to the survey. Participants were from 23 countries. Answers showed that managementof gestational Atypical Ductal Hyperplasia (ADH) and Lobular Neoplasia (LN) was readily postponed by surgeons in favor of fetus safety while beingcautious about risks of conservative management alone.Conclusion: Various methods of treatment are selected by surgeons for managing high-risk breast lesions during pregnancy. In the absence of relevantliterature, decision making in a multidisciplinary team would be the best approach in these cases.

Anahtar Kelime:

Belge Türü: Makale Makale Türü: Araştırma Makalesi Erişim Türü: Erişime Açık

1. Yu JH, Kim MJ, Cho H, Liu HJ, Han SJ, Ahn TG. Breast diseases during pregnancy and lactation. Obstet Gynecol Sci 2013; 56: 143-159. (PMID: 24327995)
2. Olfatbakhsh A, Gholizadeh Z, Beheshtiyan T, Hoseinpour P. Five-year Study of Patients with Lactating Adenoma and Review of the Literature. Arch Breast Cancer 2015; 30: 125-128.
3. Cardonick E. Pregnancy-associated breast cancer: optimal treatment options. Int J Womens Health 2014; 6: 935-943. (PMID: 25395871)
4. Basaran D, Turgal M, Beksac K, Ozyuncu O, Aran O, Beksac MS. Pregnancy-associated breast cancer: clinicopathological characteristics of 20 cases with a focus on identifiable causes of diagnostic delay. Breast Care 2014; 9: 355-359. (PMID: 25759617)
5. Langer A, Mohallem M, Stevens D, Rouzier R, Lerebours F, Chérel P. A single-institution study of 117 pregnancy-associated breast cancers (PABC): presentation, imaging, clinicopathological data and outcome. Diag Interv Imaging 2014; 95: 435-441. (PMID: 24485752)
6. Allison KH, Jensen KC. Intraductal Proliferations (DCIS, ADH, and UDH). Shin SJ, editor. A Comprehensive Guide to Core Needle Biopsies of the Breast. Springer; 2016. p. 337-376.
7. Schnitt SJ, Collins LC. Intraductal proliferative lesions: Usual Ductal Hyperplasia, Atypical Ductal Hyperplasia, And Ductal Carcinoma In Situ. Schnitt SJ, Collins LC, editors. Biopsy interpretation of the breast. Wolters Kluwer; 2018. p. 96-168. 8. Calhoun BC. Core needle biopsy of the breast: an evaluation of contemporary data. Surg Path Clin 2018; 11: 1-16. (PMID: 29413652)
9. Hartmann LC, Degnim AC, Santen RJ, Dupont WD, Ghosh K. Atypical hyperplasia of the breast-risk assessment and management options. N Engl J Med 2015; 372: 78-89. (PMID: 25551530)
10. Kader T, Hill P, Rakha EA, Campbell IG, Gorringe KL. Atypical ductal hyperplasia: update on diagnosis, management, and molecular landscape. Breast Cancer Res 2018; 20: 39. (PMID: 29720211)
11. Simpson JF, Schnitt SJ, Visscher D, Vijver MJvd, Ellis IO. Atypical ductal hyperplasia. Lakhani SR, Stuart IOE, Schnitt J, Tan PH, Vijver MJvd, editors. WHO Classification of Tumours of the Breast. International Agency for Research on Cancer; 2012. p. 88-89.
12. Dion L, Racin A, Brousse S, Beltjens F, Cauchois A, Levêque J, et al. Atypical epithelial hyperplasia of the breast: state of the art. Expert Rev Anticancer Ther 2016; 16: 943-953. (PMID: 27367571)
13. Lakhani SR, Schnitt SJ, O'Malley F, Vijver MJvd, Palacios PTSJ. Lobular Neoplasia. Lakhani SR, Ellis IO, Schnitt SJ, Tan PH, Vijver MJvd, editors. WHO Classification of Tumours of the Breast. International Agency for Research on Cancer; 2012. p. 77-80.
14. Hoda SA. Ductal Hyperplasia: Usual and Atypical. Hoda SA, Brogi E, Koerner FC, Rosen PP, editors. Rosen's Breast Pathology. Wolters Kluwer; 2015. p. 271- 307.
15. Mesurolle B, Perez JC, Azzumea F, Lemercier E, Xie X, Aldis A, Omeroglu A, Meterissian S. Atypical ductal hyperplasia diagnosed at sonographically guided core needle biopsy: frequency, final surgical outcome, and factors associated with underestimation. AJR Am J Roentgenol 2014; 202: 1389-1394. (PMID: 24848840)
16. Peña A, Shah SS, Fazzio RT, Hoskin TL, Brahmbhatt RD, Hieken TJ, Jakub JW, Boughey JC, Visscher DW, Degnim AC. Multivariate model to identify women at low risk of cancer upgrade after a core needle biopsy diagnosis of atypical ductal hyperplasia. Breast Cancer Res Treat 2017; 164: 295-304. (PMID: 28474262)
17. Collins LC. Precursor Lesions of the Low-Grade Breast Neoplasia Pathway. Surg Pathol Clin 2018; 11: 177-197. (PMID: 29413656)
18. Clauser P, Marino MA, Baltzer PA, Bazzocchi M, Zuiani C. Management of atypical lobular hyperplasia, atypical ductal hyperplasia, and lobular carcinoma in situ. Expert Rev Anticancer Ther 2016; 16: 335-346. (PMID: 26780850)
19. Kwong A, Shek T. Factors affecting the under-diagnosis of atypical ductal hyperplasia diagnosed by core needle biopsies-A 10-year retrospective study and review of the literature. Int J Surg 2018; 49: 27-31. (PMID: 29146271)
20. Sasaki J, Geletzke A, Kass RB, Klimberg VS, Copeland EM, Bland KI. Etiology and Management of Benign Breast Disease. Bland KI, Copeland III EM, Klimberg VS, Gradisha WJ, editors. The Breast: Comprehensive Management of Benign and Malignant Diseases. Elsevier; 2018. p. 79-92.
21. Nakhlis F, Gilmore L, Gelman R, Bedrosian I, Ludwig K, Hwang ES, Willey S, Hudis C, Iglehart JD, Lawler E, Ryabin NY, Golshan M, Schnitt SJ, King TA. Incidence of adjacent synchronous invasive carcinoma and/or ductal carcinoma in-situ in patients with lobular neoplasia on core biopsy: results from a prospective multi-institutional registry (TBCRC 020). Ann Surg Oncol 2016; 23: 722-728. (PMID: 26542585)
22. Calhoun BC, Grobmyer SR, Simpson JF. Benign, High-Risk, and Premalignant Lesions of the Breast. Bland KI, Copeland III EM, Klimberg VS, Gradisha WJ, editors. The Breast: Comprehensive Management of Benign and Malignant Diseases. Elsevier; 2018. p. 116-129.
23. Orr B, Kelley III JL. Benign breast diseases: evaluation and management. Clin Obstet Gynecol 2016; 59: 710-726. (PMID: 27660928)
24. Danforth DN. Molecular profile of atypical hyperplasia of the breast. Breast Cancer Res Treat 2018; 167: 9-29. (PMID: 28913734)
25. Menen RS, Ganesan N, Bevers T, Ying J, Coyne R, Lane D, et al. Long-term safety of observation in selected women following core biopsy diagnosis of atypical ductal hyperplasia. Ann Surg Oncol 2017; 24: 70-76. (PMID: 27573525) [CrossRef]
26. Rageth CJ, O'Flynn EA, Comstock C, Kurtz C, Kubik R, Madjar H, Lepori D, Kampmann G, Mundinger A, Baege A, Decker T, Hosch S, Tausch C, Delaloye JF, Morris E, Varga Z. First International Consensus Conference on lesions of uncertain malignant potential in the breast (B3 lesions). Breast Cancer Res Treat 2016; 159: 203-213. (PMID: 27522516)
27. Hwang H, Sahoo S. Atypical Lobular Hyperplasia and Lobular Carcinoma In Situ. Shin SJ, editor. A Comprehensive Guide to Core Needle Biopsies of the Breast. Springer; 2016. p. 561-594.
28. Vogel VG. Follow-up of the breast cancer prevention trial and the future of breast cancer prevention efforts. Clin Cancer Res 2001; 7: 4413s-4418s. (PMID: 11916233)

APA	Alipour S, omranipour r, Amant F, Eslami B (2020). Atypical Lesions of the Breast and Lobular Carcinoma in Situ in Pregnancy – Surgeons’ Practice. , 16 - 21. 10.5152/ejbh.2019.5158
Chicago	Alipour Sadaf,omranipour ramesh,Amant Frédéric,Eslami Bita Atypical Lesions of the Breast and Lobular Carcinoma in Situ in Pregnancy – Surgeons’ Practice. (2020): 16 - 21. 10.5152/ejbh.2019.5158
MLA	Alipour Sadaf,omranipour ramesh,Amant Frédéric,Eslami Bita Atypical Lesions of the Breast and Lobular Carcinoma in Situ in Pregnancy – Surgeons’ Practice. , 2020, ss.16 - 21. 10.5152/ejbh.2019.5158
AMA	Alipour S,omranipour r,Amant F,Eslami B Atypical Lesions of the Breast and Lobular Carcinoma in Situ in Pregnancy – Surgeons’ Practice. . 2020; 16 - 21. 10.5152/ejbh.2019.5158
Vancouver	Alipour S,omranipour r,Amant F,Eslami B Atypical Lesions of the Breast and Lobular Carcinoma in Situ in Pregnancy – Surgeons’ Practice. . 2020; 16 - 21. 10.5152/ejbh.2019.5158
IEEE	Alipour S,omranipour r,Amant F,Eslami B "Atypical Lesions of the Breast and Lobular Carcinoma in Situ in Pregnancy – Surgeons’ Practice." , ss.16 - 21, 2020. 10.5152/ejbh.2019.5158
ISNAD	Alipour, Sadaf vd. "Atypical Lesions of the Breast and Lobular Carcinoma in Situ in Pregnancy – Surgeons’ Practice". (2020), 16-21. https://doi.org/10.5152/ejbh.2019.5158

APA	Alipour S, omranipour r, Amant F, Eslami B (2020). Atypical Lesions of the Breast and Lobular Carcinoma in Situ in Pregnancy – Surgeons’ Practice. European Journal of Breast Health, 16(1), 16 - 21. 10.5152/ejbh.2019.5158
Chicago	Alipour Sadaf,omranipour ramesh,Amant Frédéric,Eslami Bita Atypical Lesions of the Breast and Lobular Carcinoma in Situ in Pregnancy – Surgeons’ Practice. European Journal of Breast Health 16, no.1 (2020): 16 - 21. 10.5152/ejbh.2019.5158
MLA	Alipour Sadaf,omranipour ramesh,Amant Frédéric,Eslami Bita Atypical Lesions of the Breast and Lobular Carcinoma in Situ in Pregnancy – Surgeons’ Practice. European Journal of Breast Health, vol.16, no.1, 2020, ss.16 - 21. 10.5152/ejbh.2019.5158
AMA	Alipour S,omranipour r,Amant F,Eslami B Atypical Lesions of the Breast and Lobular Carcinoma in Situ in Pregnancy – Surgeons’ Practice. European Journal of Breast Health. 2020; 16(1): 16 - 21. 10.5152/ejbh.2019.5158
Vancouver	Alipour S,omranipour r,Amant F,Eslami B Atypical Lesions of the Breast and Lobular Carcinoma in Situ in Pregnancy – Surgeons’ Practice. European Journal of Breast Health. 2020; 16(1): 16 - 21. 10.5152/ejbh.2019.5158
IEEE	Alipour S,omranipour r,Amant F,Eslami B "Atypical Lesions of the Breast and Lobular Carcinoma in Situ in Pregnancy – Surgeons’ Practice." European Journal of Breast Health, 16, ss.16 - 21, 2020. 10.5152/ejbh.2019.5158
ISNAD	Alipour, Sadaf vd. "Atypical Lesions of the Breast and Lobular Carcinoma in Situ in Pregnancy – Surgeons’ Practice". European Journal of Breast Health 16/1 (2020), 16-21. https://doi.org/10.5152/ejbh.2019.5158